Stock Performance Overview
On 6 Jan 2026, National Peroxide Ltd closed just 0.63% above its 52-week low of ₹441.1, underscoring the stock’s proximity to historic lows. The share price has underperformed consistently across multiple time frames, with a one-day decline of 1.05% compared to the Sensex’s 0.45% fall. Over the past week, the stock has dropped 5.47%, while the Sensex gained 0.45%. The one-month performance shows a sharper fall of 11.63% against the Sensex’s modest 0.77% decline.
More notably, the three-month return for National Peroxide Ltd stands at -25.72%, contrasting with the Sensex’s 3.99% gain. The stock’s one-year performance is particularly stark, with a 45.36% loss compared to the Sensex’s 9.09% rise. Year-to-date, the stock has fallen 5.56%, while the Sensex has declined marginally by 0.20%. Over longer horizons, the stock has failed to generate any returns in the last three, five, and ten years, while the Sensex has delivered 41.99%, 76.55%, and 234.77% gains respectively.
National Peroxide Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish trend.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Financial and Operational Metrics
The company’s financial indicators reveal considerable strain. National Peroxide Ltd’s operating profits have contracted at a compounded annual growth rate (CAGR) of -135.58% over the past five years, signalling a significant erosion in core profitability. The average EBIT to interest coverage ratio stands at a low 0.14, highlighting challenges in servicing debt obligations effectively.
Return on equity (ROE) has averaged a modest 1.90%, reflecting limited profitability generated from shareholders’ funds. The latest six-month profit after tax (PAT) was ₹1.28 crore, representing a decline of 77.78% compared to the previous period. Additionally, non-operating income for the quarter accounted for 263.49% of profit before tax (PBT), indicating reliance on income sources outside the company’s primary business activities.
Market Risk and Valuation Concerns
The stock is considered risky relative to its historical valuation norms. Over the last year, while the stock has delivered a negative return of 45.36%, its profits have fallen by 113%, underscoring deteriorating earnings quality. This underperformance extends beyond the short term, with the stock lagging the BSE500 index over one-year, three-month, and three-year periods.
National Peroxide Ltd’s Mojo Score currently stands at 12.0, with a Mojo Grade of Strong Sell, upgraded from Sell on 7 May 2025. The company’s market capitalisation grade is rated 4, reflecting its micro-cap status within the commodity chemicals sector.
Shareholding and Sector Context
The majority shareholding remains with promoters, maintaining concentrated ownership. The company operates within the commodity chemicals industry, a sector that has seen varied performance across peers. Despite the sector’s overall resilience, National Peroxide Ltd’s share price trajectory has diverged markedly, reflecting company-specific factors.
Why settle for National Peroxide Ltd? SwitchER evaluates this Commodity Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Comparative Sector and Market Performance
While National Peroxide Ltd has struggled, the broader commodity chemicals sector has demonstrated mixed results, with some companies maintaining stable earnings and share price appreciation. The Sensex’s positive returns over the past year and longer periods further highlight the stock’s relative underperformance.
The company’s inability to generate positive returns over three, five, and ten years contrasts sharply with the Sensex’s robust gains of 41.99%, 76.55%, and 234.77% respectively, emphasising the stock’s prolonged stagnation.
Summary of Key Metrics
To summarise, National Peroxide Ltd’s stock has reached an all-time low amid a sustained decline in share price and profitability. The company’s financial health is marked by weak operating profit growth, low interest coverage, and minimal returns on equity. The stock’s performance has lagged significantly behind benchmark indices and sector peers, with recent trading confirming a continuation of this trend.
These factors collectively contribute to the stock’s current Strong Sell rating and low Mojo Score, reflecting the challenges faced by the company in the current market environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
